Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chembio Diagnostics (CEMI)

Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,710
  • Shares Outstanding, K 36,726
  • Annual Sales, $ 49,520 K
  • Annual Income, $ -23,290 K
  • 60-Month Beta 1.85
  • Price/Sales 0.34
  • Price/Cash Flow N/A
  • Price/Book 0.94
Trade CEMI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.73
  • Most Recent Earnings $-0.21 on 11/03/22
  • Latest Earnings Date 05/04/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3540 +28.53%
on 03/28/23
0.4680 -2.78%
on 04/17/23
+0.1050 (+30.00%)
since 03/27/23
3-Month
0.3200 +42.19%
on 03/16/23
0.4680 -2.78%
on 04/17/23
+0.1049 (+29.96%)
since 01/27/23
52-Week
0.1900 +139.47%
on 12/29/22
1.2400 -63.31%
on 08/04/22
-0.1660 (-26.73%)
since 04/27/22

Most Recent Stories

More News
Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer

/PRNewswire/ -- Life Science Outsourcing, Inc. ("LSO"), a premier contract manufacturer and value-added service provider for the medical device and life...

CEMI : 0.4550 (+0.22%)
APTV : 69.32 (-0.04%)
Shareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with Biosynex

/PRNewswire/ -- Ademi LLP is investigating Chembio (NASDAQ: CEMI) for possible breaches of fiduciary duty and other violations of law in its transaction with...

CEMI : 0.4550 (+0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CINC, DCT, ANGN, CEMI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CINC : 29.06 (-0.48%)
DCT : 18.99 (unch)
ANGN : 10.0000 (+2.04%)
CEMI : 0.4550 (+0.22%)
Moore Kuehn Encourages ALR, CEMI, LPTX, and ATCX Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

ALR : 1.3200 (+0.76%)
CEMI : 0.4550 (+0.22%)
LPTX : 2.96 (-1.33%)
ATCX : 12.25 (+0.66%)
CHEMBIO DIAGNOSTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chembio Diagnostics, Inc. - CEMI

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Chembio Diagnostics, Inc. (NasdaqCM: CEMI)...

CEMI : 0.4550 (+0.22%)
STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Chembio Diagnostics, Inc. - CEMI

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

CEMI : 0.4550 (+0.22%)
CEMI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chembio Diagnostics, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Chembio Diagnostics, Inc. (NASDAQ: CEMI) to Biosynex SA for $0.45 per share is fair to Chembio shareholders.

CEMI : 0.4550 (+0.22%)
Chembio Diagnostics to Report Second Quarter 2022 Financial Results on August 4, 2022

HAUPPAUGE, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on...

CEMI : 0.4550 (+0.22%)
Chembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channel

Initiates distribution of SCoV-2 Ag Detect Self-Test to consumers in the United States and expansion of SURE CHECK HIV Self-Test distribution to consumers...

CEMI : 0.4550 (+0.22%)
Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors

HAUPPAUGE, N.Y., May 24, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused...

CEMI : 0.4550 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK...

See More

Key Turning Points

3rd Resistance Point 0.4657
2nd Resistance Point 0.4603
1st Resistance Point 0.4577
Last Price 0.4550
1st Support Level 0.4497
2nd Support Level 0.4443
3rd Support Level 0.4417

See More

52-Week High 1.2400
Fibonacci 61.8% 0.8389
Fibonacci 50% 0.7150
Fibonacci 38.2% 0.5911
Last Price 0.4550
52-Week Low 0.1900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar